This was discussed by Gerald in the Sept 2014 busi
Post# of 30028
Gerald:
Quote:PhenoGuard could potentially be the greatest asset the company has. Look at how many studies are being done with MANF. Just imagine the number of studies and possible treatments emanating from the proteins that are likely to be discovered in this process. Amarantus could potentially dwarf the success of Amgen at some point.
"The very first cell line led to the discovery of the MANF family of proteins. We have 87 other cell lines in our freezer. And we are now in a cell line expanding mode to try to increase the number of cell lines before we engage in a very strong iterative discovery process. We have a high degree of confidence that we will be able to discover more proteins."